User:Mr. Ibrahem/Idarucizumab

Idarucizumab, sold under the brand name Praxbind, is a medication used to reverse the effects of dabigatran. Specifically it is used if severe bleeding or urgent surgery is required. It is given by injection into a vein.

Common side effects include headache, nausea, and constipation. Severe side effects may include blood clots and allergic reactions. It is a monoclonal antibody that works by binding to and inactivating dabigatran.

Idarucizumab was approved for medical use in the United States and Europe in 2015. In the United Kingdom it costs the NHS about £2,400 for a dose as of 2021. This amount in the United States costs about 4,500 USD.